These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17344302)

  • 61. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    Cao J; McNevin J; Holte S; Fink L; Corey L; McElrath MJ
    J Virol; 2003 Jun; 77(12):6867-78. PubMed ID: 12768006
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.
    Jennes W; Camara M; Dièye T; Mboup S; Kestens L
    J Virol; 2008 Sep; 82(17):8619-28. PubMed ID: 18562522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection.
    Day CL; Kiepiela P; Leslie AJ; van der Stok M; Nair K; Ismail N; Honeyborne I; Crawford H; Coovadia HM; Goulder PJ; Walker BD; Klenerman P
    J Virol; 2007 Jan; 81(1):434-8. PubMed ID: 17050606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
    Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
    J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
    Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D
    PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
    Oxenius A; Yerly S; Ramirez E; Phillips RE; Price DA; Perrin L
    AIDS; 2001 Sep; 15(13):1653-6. PubMed ID: 11546939
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
    Van Gulck ER; Ponsaerts P; Heyndrickx L; Vereecken K; Moerman F; De Roo A; Colebunders R; Van den Bosch G; Van Bockstaele DR; Van Tendeloo VF; Allard S; Verrier B; Marañón C; Hoeffel G; Hosmalin A; Berneman ZN; Vanham G
    Blood; 2006 Mar; 107(5):1818-27. PubMed ID: 16263796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Upregulated PD-1 on CD8
    Xiao J; Liu X; Yu X; Dong Y; Wang X; Leng J; Yang R; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1372-1377. PubMed ID: 27667465
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.
    Horton H; Havenar-Daughton C; Lee D; Moore E; Cao J; McNevin J; Andrus T; Zhu H; Rubin A; Zhu T; Celum C; McElrath MJ
    J Virol; 2006 Oct; 80(19):9779-88. PubMed ID: 16973582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
    Ferre AL; Hunt PW; Critchfield JW; Young DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    Blood; 2009 Apr; 113(17):3978-89. PubMed ID: 19109229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intracellular and cell-free (infectious) HIV-1 in rectal mucosa.
    Di Stefano M; Favia A; Monno L; Lopalco P; Caputi O; Scardigno AC; Pastore G; Fiore JR; Angarano G
    J Med Virol; 2001 Dec; 65(4):637-43. PubMed ID: 11745925
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles.
    Xu J; Whitman L; Lori F; Lisziewicz J
    AIDS; 2002 Sep; 16(14):1849-57. PubMed ID: 12351944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
    Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
    AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses.
    Snyder-Cappione JE; Divekar AA; Maupin GM; Jin X; Demeter LM; Mosmann TR
    J Immunol; 2006 Feb; 176(4):2662-8. PubMed ID: 16456029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.
    Fraser DG; Oaks JL; Brown WC; McGuire TC
    Immunology; 2002 Mar; 105(3):295-305. PubMed ID: 11918691
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impaired IFN-gamma production by viral immunodominant peptide-specific tetramer+ CD8+ T cells in HIV-1 infected patients is not secondary to HAART.
    Onlamoon N; Pattanapanyasat K; Ansari AA
    Clin Dev Immunol; 2004; 11(3-4):287-98. PubMed ID: 15559376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.
    Gray CM; Mlotshwa M; Riou C; Mathebula T; de Assis Rosa D; Mashishi T; Seoighe C; Ngandu N; van Loggerenberg F; Morris L; Mlisana K; Williamson C; Karim SA;
    J Virol; 2009 Jan; 83(1):470-8. PubMed ID: 18945774
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
    Alatrakchi N; Damond F; Matheron S; Beretta-Tempelhoff S; Campa P; Carcelain G; Brun-Vezinet F; Autran B;
    AIDS; 2006 Jan; 20(1):29-34. PubMed ID: 16327316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional.
    Bere A; Denny L; Naicker P; Burgers WA; Passmore JA
    Immunology; 2013 Jul; 139(3):342-51. PubMed ID: 23374084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.